259 related articles for article (PubMed ID: 12538634)
1. Thyroid hormone regulates hepatic triglyceride mobilization and apolipoprotein B messenger ribonucleic Acid editing in a murine model of congenital hypothyroidism.
Mukhopadhyay D; Plateroti M; Anant S; Nassir F; Samarut J; Davidson NO
Endocrinology; 2003 Feb; 144(2):711-9. PubMed ID: 12538634
[TBL] [Abstract][Full Text] [Related]
2. Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor.
Anant S; Henderson JO; Mukhopadhyay D; Navaratnam N; Kennedy S; Min J; Davidson NO
J Biol Chem; 2001 Dec; 276(50):47338-51. PubMed ID: 11577082
[TBL] [Abstract][Full Text] [Related]
3. Identification of GRY-RBP as an apolipoprotein B RNA-binding protein that interacts with both apobec-1 and apobec-1 complementation factor to modulate C to U editing.
Blanc V; Navaratnam N; Henderson JO; Anant S; Kennedy S; Jarmuz A; Scott J; Davidson NO
J Biol Chem; 2001 Mar; 276(13):10272-83. PubMed ID: 11134005
[TBL] [Abstract][Full Text] [Related]
4. Metabolic regulation of apoB mRNA editing is associated with phosphorylation of APOBEC-1 complementation factor.
Lehmann DM; Galloway CA; Sowden MP; Smith HC
Nucleic Acids Res; 2006; 34(11):3299-308. PubMed ID: 16820530
[TBL] [Abstract][Full Text] [Related]
5. Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits.
Hughes SD; Rouy D; Navaratnam N; Scott J; Rubin EM
Hum Gene Ther; 1996 Jan; 7(1):39-49. PubMed ID: 8825867
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel alternative splice variants of APOBEC-1 complementation factor with different capacities to support apolipoprotein B mRNA editing.
Sowden MP; Lehmann DM; Lin X; Smith CO; Smith HC
J Biol Chem; 2004 Jan; 279(1):197-206. PubMed ID: 14570923
[TBL] [Abstract][Full Text] [Related]
7. ARCD-1, an apobec-1-related cytidine deaminase, exerts a dominant negative effect on C to U RNA editing.
Anant S; Mukhopadhyay D; Sankaranand V; Kennedy S; Henderson JO; Davidson NO
Am J Physiol Cell Physiol; 2001 Dec; 281(6):C1904-16. PubMed ID: 11698249
[TBL] [Abstract][Full Text] [Related]
8. Targeted deletion of the murine apobec-1 complementation factor (acf) gene results in embryonic lethality.
Blanc V; Henderson JO; Newberry EP; Kennedy S; Luo J; Davidson NO
Mol Cell Biol; 2005 Aug; 25(16):7260-9. PubMed ID: 16055734
[TBL] [Abstract][Full Text] [Related]
9. Tissue-specific inhibition of apolipoprotein B mRNA editing in the liver by adenovirus-mediated transfer of a dominant negative mutant APOBEC-1 leads to increased low density lipoprotein in mice.
Oka K; Kobayashi K; Sullivan M; Martinez J; Teng BB; Ishimura-Oka K; Chan L
J Biol Chem; 1997 Jan; 272(3):1456-60. PubMed ID: 8999814
[TBL] [Abstract][Full Text] [Related]
10. Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting.
Hersberger M; Patarroyo-White S; Qian X; Arnold KS; Rohrer L; Balestra ME; Innerarity TL
Biochem J; 2003 Jan; 369(Pt 2):255-62. PubMed ID: 12374571
[TBL] [Abstract][Full Text] [Related]
11. REPR and complementation factor(s) interact to modulate rat apolipoprotein B mRNA editing in response to alterations in cellular cholesterol flux.
Inui Y; Giannoni F; Funahashi T; Davidson NO
J Lipid Res; 1994 Aug; 35(8):1477-89. PubMed ID: 7989872
[TBL] [Abstract][Full Text] [Related]
12. Recapture of hepatic apolipoprotein B mRNA editing may be a promising strategy to relieve nephrotic dyslipidemia.
Hu P; Lu L; Hu B; Qin YH
Med Hypotheses; 2010 Dec; 75(6):561-3. PubMed ID: 20705399
[TBL] [Abstract][Full Text] [Related]
13. Metabolic regulation of APOBEC-1 complementation factor trafficking in mouse models of obesity and its positive correlation with the expression of ApoB protein in hepatocytes.
Galloway CA; Ashton J; Sparks JD; Mooney RA; Smith HC
Biochim Biophys Acta; 2010 Nov; 1802(11):976-85. PubMed ID: 20541607
[TBL] [Abstract][Full Text] [Related]
14. APOLIPOPROTEIN B: mRNA editing, lipoprotein assembly, and presecretory degradation.
Davidson NO; Shelness GS
Annu Rev Nutr; 2000; 20():169-93. PubMed ID: 10940331
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA.
Mehta A; Kinter MT; Sherman NE; Driscoll DM
Mol Cell Biol; 2000 Mar; 20(5):1846-54. PubMed ID: 10669759
[TBL] [Abstract][Full Text] [Related]
16. Tissue-specific, developmental and nutritional regulation of the gene encoding the catalytic subunit of the rat apolipoprotein B mRNA editing enzyme: functional role in the modulation of apoB mRNA editing.
Funahashi T; Giannoni F; DePaoli AM; Skarosi SF; Davidson NO
J Lipid Res; 1995 Mar; 36(3):414-28. PubMed ID: 7775854
[TBL] [Abstract][Full Text] [Related]
17. Disproportionate relationship between APOBEC-1 expression and apolipoprotein B mRNA editing activity.
Siddiqui JF; Van Mater D; Sowden MP; Smith HC
Exp Cell Res; 1999 Oct; 252(1):154-64. PubMed ID: 10502408
[TBL] [Abstract][Full Text] [Related]
18. Mouse models as tools to explore cytidine-to-uridine RNA editing.
Cho SJ; Blanc V; Davidson NO
Methods Enzymol; 2007; 424():417-35. PubMed ID: 17662852
[TBL] [Abstract][Full Text] [Related]
19. ApoB mRNA editing is mediated by a coordinated modulation of multiple apoB mRNA editing enzyme components.
Chen Z; Eggerman TL; Patterson AP
Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G53-65. PubMed ID: 16920700
[TBL] [Abstract][Full Text] [Related]
20. Identification of domains in apobec-1 complementation factor required for RNA binding and apolipoprotein-B mRNA editing.
Mehta A; Driscoll DM
RNA; 2002 Jan; 8(1):69-82. PubMed ID: 11871661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]